Found: 21
Select item for more details and to access through your institution.
A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 4, p. 1028, doi. 10.1007/s10637-020-01054-6
- By:
- Publication type:
- Article
Tandem high?dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: A monocenter prospective study.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 2, p. 122, doi. 10.1002/ajh.20790
- By:
- Publication type:
- Article
Prophylaxis of central venous catheter‐related thrombosis with minidose warfarin in patients treated with high‐dose chemotherapy and peripheral‐blood stem‐cell transplantation: Retrospective analysis of 228 cancer patients.
- Published in:
- American Journal of Hematology, 2006, v. 81, n. 1, p. 1, doi. 10.1002/ajh.20512
- By:
- Publication type:
- Article
Primary mediastinal B-cell lymphoma with sclerosis: Report of 11 cases treated with intensified-CHOP plus radiotherapy.
- Published in:
- American Journal of Hematology, 2005, v. 78, n. 4, p. 312, doi. 10.1002/ajh.20301
- By:
- Publication type:
- Article
Solitary plasmacytoma of the duodenum.
- Published in:
- American Journal of Hematology, 2004, v. 76, n. 2, p. 185, doi. 10.1002/ajh.10468
- By:
- Publication type:
- Article
Feasibility and toxicity of high-dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non-Hodgkin's lymphoma: Survey from a single institution.
- Published in:
- American Journal of Hematology, 2003, v. 73, n. 4, p. 267, doi. 10.1002/ajh.10384
- By:
- Publication type:
- Article
A First-in-human Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor, in Patients With Relapsed/Refractory Hematologic Malignancies: Results From the European Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
PD-1 Inhibitors May Restore Chemo-sensitivity in Relapsed/Refractory Classical Hodgkin Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S308, doi. 10.1016/j.clml.2019.07.272
- By:
- Publication type:
- Article
Bendamustine in Combination with Gemcitabine and Vinorelbine (BEGEV) is an Effective Regimen for Heavily Pretreated, Relapsed or Refractory Hodgkin Lymphoma Patients: A Retrospective Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S234, doi. 10.1016/j.clml.2018.07.116
- By:
- Publication type:
- Article
Herpes Infections in Breast Cancer Patients Treated with Adjuvant Chemotherapy.
- Published in:
- Oncology, 2006, v. 71, n. 3/4, p. 164, doi. 10.1159/000106065
- By:
- Publication type:
- Article
Predictive value of early 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) during salvage chemotherapy in relapsing/refractory Hodgkin lymphoma (HL) treated with high-dose chemotherapy.
- Published in:
- British Journal of Haematology, 2009, v. 145, n. 3, p. 369, doi. 10.1111/j.1365-2141.2009.07645.x
- By:
- Publication type:
- Article
High incidence of haemostatic interference in cancer patients treated with FOLFOX regimen and concomitant minidose of warfarin.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Cardiac involvement in non-Hodgkin's lymphoma.
- Published in:
- British Journal of Haematology, 2002, v. 119, n. 4, p. 887, doi. 10.1046/j.1365-2141.2002.03868.x
- By:
- Publication type:
- Article
Translating the Biology of Diffuse Large B-cell Lymphoma Into Treatment.
- Published in:
- Oncologist, 2022, v. 27, n. 1, p. 57, doi. 10.1093/oncolo/oyab004
- By:
- Publication type:
- Article
Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1236, doi. 10.1634/theoncologist.2019-0138
- By:
- Publication type:
- Article
Modulated Chemotherapy According to Modified Comprehensive Geriatric Assessment in 100 Consecutive Elderly Patients with Diffuse Large B-Cell Lymphoma.
- Published in:
- Oncologist, 2012, v. 17, n. 6, p. 838, doi. 10.1634/theoncologist.2011-0417
- By:
- Publication type:
- Article
CD34<sup>+</sup> dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.
- Published in:
- European Journal of Haematology, 2007, v. 78, n. 2, p. 111, doi. 10.1111/j.1600-0609.2006.00793.x
- By:
- Publication type:
- Article
Outcome after chimeric antigen receptor (CAR) T‐cell therapy failure in large B‐cell lymphomas.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 1, p. 151, doi. 10.1111/bjh.19057
- By:
- Publication type:
- Article
Chemotherapy after PD‐1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 1, p. 82, doi. 10.1111/bjh.18183
- By:
- Publication type:
- Article
Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 69, doi. 10.1111/bjh.12845
- By:
- Publication type:
- Article
Comparison of prognostic models in patients with advanced Hodgkin disease. Promising results from integration of the best three systems.
- Published in:
- 2001
- By:
- Publication type:
- journal article